BioLife Solutions, Inc. 8-K Filing: Key Updates You Need to Know!
From the provided section of the financial report, the following key information and insights can be extracted:
- Filing Type: The report is an 8-K filing, which is used to disclose significant events that shareholders should know about, such as acquisitions, financial results, or changes in the company.
- Company Information:
- Name: BioLife Solutions, Inc.
- CIK (Central Index Key): 0000834365
- Ticker Symbol: BLFS
- Exchange: NASDAQ
- Incorporation State: Delaware (DE)
- Employer Identification Number (EIN): 94-3076866
- Address: 3303 Monte Villa Parkway, Bothell, WA 98021
- Contact Number: 425-402-1400
- Reporting Period:
- Start Date: November 12, 2024
- End Date: November 12, 2024
- This indicates that the report likely covers a specific event or information that occurred on that single day.
- Stock Information:
- Common Stock Par Value: $0.001 per share
- XML and XBRL Context: The document is formatted in XML/XBRL, which is a standard for communicating financial data. The schema reference (blfs-20241216.xsd) indicates the specific format used for this filing.
Insights:
- The filing is current and pertains to a specific date, indicating that it may address an immediate or recent event relevant to investors and stakeholders.
- As an 8-K filing, it typically means that there is significant information that may impact the stock's performance or the company's operational status.
- The fact that the report is linked to a specific schema suggests adherence to regulatory standards for transparency and accuracy in financial reporting.
This information can be crucial for investors, analysts, and stakeholders to assess the company's current situation and potential impacts on investment decisions.